Look no further for comprehensive and solutions-focused content aimed at keeping your facility on the pulse of changing regulations, ensuring quality and compliance within compounding systems and processes and providing implementable tactics to leverage the latest innovations within the evolving compounding landscape. Featuring expert perspective from FDA, Merck, Nephron Pharmaceuticals, Innovative Compounding, National Association Boards of Pharmacy, Wedgewood Pharmacy, Rockefeller University Hospital, St. Jude Children's Research Hospital and so many more, do not delay in joining these influential stakeholders.
CBI, an Informa business, is the health and life sciences industry leader in providing thought leadership, actionable data, benchmarking, case studies and regulatory information through a dynamic conference platform that facilitates innovation, collaboration and elevation across the pharmaceutical, biotechnology, medical device and healthcare industries.
This post is related to:
Compounding: USP <795> Non-Sterile Resources, Compliance, Technology
